Pharmacokinetics of intravenous voriconazole in patients with liver dysfunction: A prospective study in the intensive care unit.

Xiao-Bin Lin,Fa Huang,Li Tong,Yan-Zhe Xia,Jing-Jing Wu,Jia Li,Xiao-Guang Hu,Tao Liang,Xiao-Man Liu,Guo-Ping Zhong,Chang-Jie Cai,Xiao Chen
DOI: https://doi.org/10.1016/j.ijid.2020.02.041
IF: 12.073
2020-01-01
International Journal of Infectious Diseases
Abstract:•This is the first study of pharmacokinetics (PK) of intravenous voriconazole in intensive care unit patients with liver dysfunction.•The median first trough concentration (C0) of voriconazole was 5.27 (2.61) μg/ml in patients with liver dysfunction.•The median voriconazole clearance (CL) in Child–Pugh class C patients following multiple doses was 2.04 l/h.•The median half-life (t1/2) of voriconazole in Child–Pugh class C patients following multiple doses was 60.7 h.
What problem does this paper attempt to address?